510(k) Report

510(k) · Cleared

Cleared

Passeo-35 PTA Catheter

K142379510(k) SpecialCleared Dec 5, 2014101-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biotronik, Inc. · LIT Catheter, Angioplasty, Peripheral, Transluminal

Cleared on Dec 5, 2014 as substantially equivalent to K082933 (Biotronik, Inc., 2008) after a 101-day review. Its family tree reaches back 5 generations to 2000. 3 later devices descend from it.

Decided
Dec 5, 2014
Review
101 days
Class
Class II
Product code
LIT
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K000101 (2000). 8 ancestors in all. 3 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2005: 1 other ancestor2001: 2 other ancestors2015: 1 descendant cleared2023: 1 descendant cleared2025: 1 descendant clearedK000101 · RX Viatrac 14 Peripheral Dilatation Catheter · Guidant Corp. · 2000K020854 · Modification to Fox Pta Catheter · Jomed AG · 2002K033217 · Pheron Pta Catheter · Biotronik, Inc. · 2003K072765 · Passeo 18 · Biotronik, Inc. · 2007K082933 · Passeo-35 Pta Catheter · Biotronik, Inc. · 2008200020052010201520202025
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor3 generations back: 1 other ancestor4 generations back: 1 other ancestor 1 generation forward: 2 descendants2 generations forward: 1 descendant K082933 · Passeo-35 Pta Catheter · Biotronik, Inc. · 2008K072765 · Passeo 18 · Biotronik, Inc. · 2007K033217 · Pheron Pta Catheter · Biotronik, Inc. · 2003K020854 · Modification to Fox Pta Catheter · Jomed AG · 2002K000101 · RX Viatrac 14 Peripheral Dilatation Catheter · Guidant Corp. · 2000−50
  1. Root · 5 generations backK000101 RX Viatrac 14 Peripheral Dilatation CatheterGuidant Corp. · 2000
  2. 4 generations backK020854 Modification to Fox Pta CatheterJomed AG · 2002
  3. 3 generations backK033217 Pheron Pta CatheterBiotronik, Inc. · 2003
  4. 2 generations backK072765 Passeo 18Biotronik, Inc. · 2007
  5. 1 generation backK082933 Passeo-35 Pta CatheterBiotronik, Inc. · 2008
  6. This deviceK142379 Passeo-35 PTA CatheterBiotronik, Inc. · 2014
  7. Descendant · cites it directly · 1 of its ownK222065 Passeo-35 Xeo Peripheral Dilatation CatheterBiotronik, Inc. · 2023
  8. Descendant · cites it directly · 1 of its ownK152240 Passeo-14 Peripheral Dilatation CatheterBiotronik, Inc. · 2015
  9. Descendant · 2 generations on · 0 of its ownK250706 Passeo-35 Xeo Peripheral Dilatation Catheter; Passeo-18 Peripheral…Biotronik, Inc. · 2025

Most influential descendants

Showing 3 of 3 · See all
  • K222065Passeo-35 Xeo Peripheral Dilatation CatheterBiotronik, Inc. · 2023 · cites it directly1descendant
  • K152240Passeo-14 Peripheral Dilatation CatheterBiotronik, Inc. · 2015 · cites it directly1descendant
  • K250706Passeo-35 Xeo Peripheral Dilatation Catheter; Passeo-18 Peripheral Dilatation Catheters…Biotronik, Inc. · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K000101RX Viatrac 14 Peripheral Dilatation CatheterGuidant Corp.2000—
−4K020854Modification to Fox Pta CatheterJomed AG2002—
−3K033217Pheron Pta CatheterBiotronik, Inc.2003—
−2K072765Passeo 18Biotronik, Inc.2007—
−1K082933Passeo-35 Pta CatheterBiotronik, Inc.2008—
0 (this device)K142379Passeo-35 PTA CatheterBiotronik, Inc.2014—
+1K222065Passeo-35 Xeo Peripheral Dilatation CatheterBiotronik, Inc.2023—
+1K152240Passeo-14 Peripheral Dilatation CatheterBiotronik, Inc.2015—
+2K250706Passeo-35 Xeo Peripheral Dilatation Catheter; Passeo-18 Peripheral Dilatation…Biotronik, Inc.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200120
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
202310
202510
FIG. 1 — Lineage of K142379, 2000–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LIT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LIT device

  1. #1 K241040 Amethyst HP PTA OTW 0.035 Catheterscore 13.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K082933Passeo-35 Pta Catheter
Summary page 4
…Predicate Device: 510(k) # Device Name Manufacturer Date of Clearance Predicate: K082933 Passeo-35 BIOTRONIK 3-Nov-2008 General Description: The Passeo-35 Peripheral Dilatation Ca…
Biotronik, Inc.2008—

Also cleared against K082933: 1 other device →

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K222065Passeo-35 Xeo Peripheral Dilatation CatheterBiotronik, Inc.20231
K152240Passeo-14 Peripheral Dilatation CatheterBiotronik, Inc.20151

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 3 companies; a new generation was cleared every 2.2 years on median.
  • None of the 8 ancestors has a recall.
  • Of its descendants, K222065 (Biotronik, Inc., 2023) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K082933.

How does its category compare?

All LIT devices

LIT Catheter, Angioplasty, Peripheral, Transluminal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · LIT

3in 2025

2007: 62008: 82009: 72010: 132011: 102012: 192013: 142014: 122015: 192016: 112017: 92018: 62019: 42020: 92021: 42022: 82023: 62024: 62025: 32026 (partial year): 4
2007high 19 (2012) · low 3 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LIT

90in 2025

2007: 64 days median2008: 53 days median2009: 29 days median2010: 78 days median2011: 82 days median2012: 29 days median2013: 79 days median2014: 90 days median2015: 112 days median2016: 116 days median2017: 57 days median2018: 118 days median2019: 40 days median2020: 125 days median2021: 61 days median2022: 122 days median2023: 167 days median2024: 43 days median2025: 90 days median2026 (partial year): 205 days median
2007high 205 (2026) · low 29 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LIT

1in 2025

2009: 22010: 12013: 2, 2 Class I2014: 32016: 12018: 22019: 32021: 12024: 22025: 1
2007high 3 (2014) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · LIT

2,073in 2025

2007: 5772008: 5132009: 6232010: 8092011: 8572012: 1,2772013: 1,2422014: 1,1782015: 1,2792016: 1,5292017: 2,0812018: 2,1882019: 2,4052020: 2,4432021: 2,4922022: 2,1552023: 1,8072024: 1,9132025: 2,073
2007high 2,492 (2021) · low 513 (2008)2025

MAUDE reports naming product code LIT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076640577
20088530513
20097292623
201013781809
201110820857
2012192901,277
201314792 (2)1,242
2014129031,178
20151911201,279
20161111611,529
201795702,081
2018611822,188
201944032,405
2020912502,443
202146112,492
2022812202,155
2023616701,807
202464321,913
202539012,073
202642050—

What is it indicated for?

The Passeo-35 Peripheral Dilatation Catheter is indicated to dilate stenosis in the renal, iliac, femoral, popliteal and infrapopliteal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K142379: Passeo-35 PTA Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K142379

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026